Acura Pharmaceuticals, Inc. (ACUR)
OTCMKTS · Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
Dec 30, 2025, 4:00 PM EST
Acura Pharmaceuticals Market Cap
Acura Pharmaceuticals has a market cap or net worth of $33.25 thousand as of December 31, 2025. Its market cap has decreased by -99.88% in one year.
Market Cap
33.25K
Enterprise Value
n/a
Revenue
1.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since March 17, 1986, Acura Pharmaceuticals's market cap has decreased from 7.10M to 33.25K, a decrease of -99.53%. That is a compound annual growth rate of -12.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 33.25K | 150.57% |
| Dec 31, 2024 | 13.27K | 100.57% |
| Dec 29, 2023 | 6.62K | -99.80% |
| Dec 30, 2022 | 3.28M | -89.93% |
| Dec 31, 2021 | 32.54M | 615.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Glass House Brands | 710.35M |
| Elite Pharmaceuticals | 526.71M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 356.97M |
| CytoDyn | 355.55M |
| Silence Therapeutics | 287.18M |